Metraipolis › archive › dc_9967d72bf8cf

Pretreatment NPLH as a Potential Predictor of Pathologic Complete Response to Accelerated MVAC Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer:… — Europe PMC PMID:42449592

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449592
DOI
10.3390/cancers18132046
License (as archived)
solo-consultazione
Archived
2026-10-19T04:14:27.496Z
SHA-256 of the archived text
b2ccfe141100429532c45efc816728570d354dfee8fd00f00ef5c3429191bed2
Stable URL of this page
https://metraipolis.com/documento/dc_9967d72bf8cf

How to cite

Pretreatment NPLH as a Potential Predictor of Pathologic Complete Response to Accelerated MVAC Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer:… — Europe PMC PMID:42449592 — Europe PMC (en), https://europepmc.org/article/MED/42449592 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9967d72bf8cf (Metraipolis archive dc_9967d72bf8cf, sha256 b2ccfe141100429532c45efc816728570d354dfee8fd00f00ef5c3429191bed2)
BibTeX
@misc{dc9967d72bf8cf,
  title = {Pretreatment NPLH as a Potential Predictor of Pathologic Complete Response to Accelerated MVAC Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer:… — Europe PMC PMID:42449592},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449592},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9967d72bf8cf; sha256 b2ccfe141100429532c45efc816728570d354dfee8fd00f00ef5c3429191bed2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449592. Agents can read the archived copy with the MCP tool read_document.